Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.

Adashek JJ, Kurzrock R.

Open source

DOI: 10.1038/s41698-023-00487-5
Published: 2023-12-08
Container: NPJ Precis Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-023-00487-5,
  title = {Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.},
  author = {Adashek JJ and  Kurzrock R.},
  year = {2023},
  journal = {NPJ Precis Oncol},
  doi = {10.1038/s41698-023-00487-5},
  url = {https://doi.org/10.1038/s41698-023-00487-5}
}

RIS

TY  - JOUR
TI  - Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.
AU  - Adashek JJ
AU  -  Kurzrock R.
PY  - 2023
JO  - NPJ Precis Oncol
DO  - 10.1038/s41698-023-00487-5
UR  - https://doi.org/10.1038/s41698-023-00487-5
ER  -

APA

JJ, A., & R., K. (2023). Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.. NPJ Precis Oncol. https://doi.org/10.1038/s41698-023-00487-5

Source records

europe-pmc · retrieved 2026-09-26T18:05:11.213Z
doaj · retrieved 2026-09-26T18:05:11.206Z